|
1
|
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.
|
J Clin Endocrinol Metab
|
2007
|
9.77
|
|
2
|
Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.
|
J Clin Endocrinol Metab
|
2008
|
3.64
|
|
3
|
Arterial inflammation in patients with HIV.
|
JAMA
|
2012
|
3.42
|
|
4
|
Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.
|
AIDS
|
2010
|
3.27
|
|
5
|
Association of C-reactive protein and HIV infection with acute myocardial infarction.
|
J Acquir Immune Defic Syndr
|
2009
|
2.99
|
|
6
|
State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary.
|
Circulation
|
2008
|
2.17
|
|
7
|
Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides.
|
AIDS
|
2005
|
2.16
|
|
8
|
Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women.
|
J Infect Dis
|
2013
|
2.15
|
|
9
|
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.
|
J Acquir Immune Defic Syndr
|
2002
|
1.98
|
|
10
|
Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults.
|
Am J Physiol Endocrinol Metab
|
2007
|
1.97
|
|
11
|
Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system.
|
J Acquir Immune Defic Syndr
|
2012
|
1.85
|
|
12
|
Effects of etanercept in patients with the metabolic syndrome.
|
Arch Intern Med
|
2006
|
1.82
|
|
13
|
Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system.
|
J Acquir Immune Defic Syndr
|
2010
|
1.70
|
|
14
|
Medical findings in outpatients with anorexia nervosa.
|
Arch Intern Med
|
2005
|
1.69
|
|
15
|
Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers.
|
AIDS
|
2012
|
1.63
|
|
16
|
2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without subclinical high-risk coronary plaque.
|
AIDS
|
2014
|
1.56
|
|
17
|
Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size.
|
Clin Endocrinol (Oxf)
|
2012
|
1.51
|
|
18
|
TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome.
|
J Clin Endocrinol Metab
|
2010
|
1.48
|
|
19
|
Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.
|
Clin Infect Dis
|
2007
|
1.47
|
|
20
|
Determinants of skeletal loss and recovery in anorexia nervosa.
|
J Clin Endocrinol Metab
|
2006
|
1.27
|
|
21
|
Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384.
|
J Acquir Immune Defic Syndr
|
2007
|
1.27
|
|
22
|
Relationship between neck circumference and cardiometabolic parameters in HIV-infected and non-HIV-infected adults.
|
Diabetes Care
|
2011
|
1.26
|
|
23
|
Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men.
|
AIDS
|
2013
|
1.23
|
|
24
|
Effects of a lifestyle modification program in HIV-infected patients with the metabolic syndrome.
|
AIDS
|
2006
|
1.19
|
|
25
|
Mitochondrial function and insulin resistance in overweight and normal-weight children.
|
J Clin Endocrinol Metab
|
2009
|
1.19
|
|
26
|
Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients.
|
AIDS
|
2004
|
1.18
|
|
27
|
Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome.
|
Am J Physiol Endocrinol Metab
|
2007
|
1.17
|
|
28
|
Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects.
|
Clin Endocrinol (Oxf)
|
2012
|
1.17
|
|
29
|
Effects of obesity, body composition, and adiponectin on carotid intima-media thickness in healthy women.
|
J Clin Endocrinol Metab
|
2006
|
1.16
|
|
30
|
Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial.
|
J Acquir Immune Defic Syndr
|
2006
|
1.12
|
|
31
|
Altered miRNA processing disrupts brown/white adipocyte determination and associates with lipodystrophy.
|
J Clin Invest
|
2014
|
1.12
|
|
32
|
Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity.
|
J Clin Endocrinol Metab
|
2009
|
1.11
|
|
33
|
Effects of switching from lopinavir/ritonavir to atazanavir/ritonavir on muscle glucose uptake and visceral fat in HIV-infected patients.
|
AIDS
|
2009
|
1.06
|
|
34
|
Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men.
|
J Clin Endocrinol Metab
|
2010
|
1.03
|
|
35
|
Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices.
|
J Clin Endocrinol Metab
|
2003
|
1.02
|
|
36
|
Skeletal muscle phosphocreatine recovery after submaximal exercise in children and young and middle-aged adults.
|
J Clin Endocrinol Metab
|
2010
|
1.01
|
|
37
|
Relation of body composition to body mass index in HIV-infected patients with metabolic abnormalities.
|
J Acquir Immune Defic Syndr
|
2008
|
0.98
|
|
38
|
Metabolic and cardiovascular complications in HIV-infected patients: new challenges for a new age.
|
J Infect Dis
|
2012
|
0.98
|
|
39
|
Metabolic and body composition effects of newer antiretrovirals in HIV-infected patients.
|
Eur J Endocrinol
|
2014
|
0.98
|
|
40
|
Genetic analysis implicates resistin in HIV lipodystrophy.
|
AIDS
|
2008
|
0.96
|
|
41
|
Effects of aging and smoking on carotid intima-media thickness in HIV-infection.
|
AIDS
|
2013
|
0.93
|
|
42
|
Body composition and metabolic changes in HIV-infected patients.
|
J Infect Dis
|
2012
|
0.92
|
|
43
|
Effect of body mass index on peak growth hormone response to provocative testing in children with short stature.
|
J Clin Endocrinol Metab
|
2009
|
0.91
|
|
44
|
Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial.
|
J Clin Endocrinol Metab
|
2012
|
0.90
|
|
45
|
Increased epicardial adipose tissue volume in HIV-infected men and relationships to body composition and metabolic parameters.
|
AIDS
|
2010
|
0.90
|
|
46
|
Associations of cardiovascular risk factors with two surrogate markers of subclinical atherosclerosis: endothelial function and carotid intima media thickness.
|
Atherosclerosis
|
2011
|
0.88
|
|
47
|
Cardiovascular disease in HIV-positive patients.
|
AIDS
|
2005
|
0.88
|
|
48
|
Receptor activator of nuclear factor-κB ligand (RANKL) and its relationship to coronary atherosclerosis in HIV patients.
|
J Acquir Immune Defic Syndr
|
2012
|
0.88
|
|
49
|
HIV-specific immune dysregulation and atherosclerosis.
|
Curr HIV/AIDS Rep
|
2012
|
0.87
|
|
50
|
The association of growth hormone parameters with skeletal muscle phosphocreatine recovery in adult men.
|
J Clin Endocrinol Metab
|
2010
|
0.87
|
|
51
|
Inflammation, immune activation, and cardiovascular disease in HIV.
|
AIDS
|
2016
|
0.87
|
|
52
|
Immune dysregulation and vascular risk in HIV-infected patients: implications for clinical care.
|
J Infect Dis
|
2011
|
0.86
|
|
53
|
Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV.
|
AIDS
|
2016
|
0.83
|
|
54
|
Nocturnal ghrelin pulsatility and response to growth hormone secretagogues in healthy men.
|
Am J Physiol Endocrinol Metab
|
2004
|
0.83
|
|
55
|
Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine.
|
AIDS
|
2015
|
0.83
|
|
56
|
Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.
|
Clin Infect Dis
|
2012
|
0.82
|
|
57
|
Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction.
|
AIDS
|
2011
|
0.82
|
|
58
|
Estrogen sulfotransferase is expressed in subcutaneous adipose tissue of obese humans in association with TNF-alpha and SOCS3.
|
J Clin Endocrinol Metab
|
2011
|
0.82
|
|
59
|
Decreased respiratory quotient in relation to resting energy expenditure in HIV-infected and noninfected subjects.
|
Metabolism
|
2009
|
0.81
|
|
60
|
Absence of polycystic ovary syndrome features in human immunodeficiency virus-infected women despite significant hyperinsulinemia and truncal adiposity.
|
J Clin Endocrinol Metab
|
2005
|
0.80
|
|
61
|
Adrenal function in HIV infection.
|
Curr Opin Endocrinol Diabetes Obes
|
2010
|
0.80
|
|
62
|
Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity.
|
Pituitary
|
2013
|
0.80
|
|
63
|
Skeletal muscle mitochondrial function is associated with longitudinal growth velocity in children and adolescents.
|
J Clin Endocrinol Metab
|
2011
|
0.79
|
|
64
|
GH/GHRH axis in HIV lipodystrophy.
|
Pituitary
|
2009
|
0.79
|
|
65
|
Increased aldosterone among HIV-infected women with visceral fat accumulation.
|
AIDS
|
2009
|
0.79
|
|
66
|
Vascular dysfunction and cardiovascular complications.
|
Curr Opin HIV AIDS
|
2007
|
0.79
|
|
67
|
The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GH.
|
J Clin Endocrinol Metab
|
2013
|
0.79
|
|
68
|
Effects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulation.
|
Clin Endocrinol (Oxf)
|
2010
|
0.79
|
|
69
|
Imaging atherosclerotic burden and inflammation: insights into the spectrum of atherosclerotic disease in HIV.
|
J Nucl Cardiol
|
2014
|
0.78
|
|
70
|
The relationship between reduced testosterone, stimulated growth hormone secretion and increased carotid intima-media thickness in obese men.
|
Clin Endocrinol (Oxf)
|
2010
|
0.77
|
|
71
|
Adipose compartmentalization and insulin resistance among obese HIV-infected women: the role of intermuscular adipose tissue.
|
Am J Clin Nutr
|
2007
|
0.77
|
|
72
|
Effects of lifestyle modification and metformin on irisin and FGF21 among HIV-infected subjects with the metabolic syndrome.
|
Clin Endocrinol (Oxf)
|
2014
|
0.77
|
|
73
|
Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals.
|
AIDS
|
2016
|
0.76
|
|
74
|
Relation of leptin pulse dynamics to fat distribution in HIV-infected patients.
|
Am J Clin Nutr
|
2004
|
0.76
|
|
75
|
Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV.
|
AIDS
|
2017
|
0.76
|
|
76
|
Increased skeletal muscle phosphocreatine recovery after sub-maximal exercise is associated with increased carotid intima-media thickness.
|
Atherosclerosis
|
2010
|
0.75
|
|
77
|
Corrigendum: Adipose-derived circulating miRNAs regulate gene expression in other tissues.
|
Nature
|
2017
|
0.75
|
|
78
|
Epidemiology of ischemic heart disease in HIV.
|
Curr Opin HIV AIDS
|
2017
|
0.75
|
|
79
|
A dural tale.
|
J Clin Endocrinol Metab
|
2007
|
0.75
|
|
80
|
Acute hyperinsulinemia effects on systemic markers of immune activation in HIV.
|
AIDS
|
2017
|
0.75
|
|
81
|
Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.
|
AIDS
|
2017
|
0.75
|